Legal & General Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.7M Buy
185,824
+18,675
+11% +$1.98M ﹤0.01% 862
2025
Q1
$20.8M Buy
167,149
+38,375
+30% +$4.76M 0.01% 799
2024
Q4
$15.9M Sell
128,774
-6,406
-5% -$789K ﹤0.01% 921
2024
Q3
$15.1M Sell
135,180
-115,620
-46% -$12.9M ﹤0.01% 959
2024
Q2
$26.8M Sell
250,800
-111,139
-31% -$11.9M 0.01% 745
2024
Q1
$43.6M Sell
361,939
-31,295
-8% -$3.77M 0.01% 651
2023
Q4
$48.4M Sell
393,234
-18,114
-4% -$2.23M 0.02% 640
2023
Q3
$53.2M Sell
411,348
-26,838
-6% -$3.47M 0.02% 606
2023
Q2
$54.3M Sell
438,186
-28,759
-6% -$3.57M 0.02% 616
2023
Q1
$68.3M Sell
466,945
-13,783
-3% -$2.02M 0.02% 559
2022
Q4
$76.6M Sell
480,728
-10,117
-2% -$1.61M 0.03% 525
2022
Q3
$65.4M Sell
490,845
-1,718
-0.3% -$229K 0.03% 569
2022
Q2
$76.8M Sell
492,563
-1,057
-0.2% -$165K 0.03% 556
2022
Q1
$76.8M Buy
493,620
+45,373
+10% +$7.06M 0.02% 589
2021
Q4
$57.1M Sell
448,247
-6,130
-1% -$781K 0.02% 659
2021
Q3
$59.2M Sell
454,377
-21,837
-5% -$2.84M 0.02% 648
2021
Q2
$84.6M Buy
476,214
+38,163
+9% +$6.78M 0.03% 579
2021
Q1
$72M Sell
438,051
-6,698
-2% -$1.1M 0.03% 589
2020
Q4
$73.4M Sell
444,749
-5,961
-1% -$984K 0.03% 561
2020
Q3
$64.3M Buy
450,710
+52,203
+13% +$7.44M 0.03% 540
2020
Q2
$44M Buy
398,507
+45,572
+13% +$5.03M 0.02% 602
2020
Q1
$35.3M Buy
352,935
+8,495
+2% +$850K 0.02% 599
2019
Q4
$51.4M Buy
344,440
+10,480
+3% +$1.56M 0.02% 590
2019
Q3
$42.8M Buy
333,960
+5,301
+2% +$679K 0.02% 609
2019
Q2
$46.9M Sell
328,659
-6,153
-2% -$877K 0.03% 591
2019
Q1
$47.9M Buy
334,812
+72,784
+28% +$10.4M 0.03% 571
2018
Q4
$32.5M Buy
262,028
+20,277
+8% +$2.51M 0.03% 580
2018
Q3
$40.6M Buy
241,751
+456
+0.2% +$76.7K 0.03% 573
2018
Q2
$41.6M Buy
241,295
+4,268
+2% +$735K 0.03% 554
2018
Q1
$35.8M Sell
237,027
-139
-0.1% -$21K 0.03% 593
2017
Q4
$31.9M Buy
237,166
+2,499
+1% +$337K 0.02% 605
2017
Q3
$34.3M Buy
234,667
+2,829
+1% +$414K 0.03% 589
2017
Q2
$36.1M Buy
231,838
+5,493
+2% +$854K 0.03% 565
2017
Q1
$32.8M Buy
226,345
+3,594
+2% +$522K 0.03% 582
2016
Q4
$24.3M Buy
+222,751
New +$24.3M 0.02% 605